Provided by Tiger Trade Technology Pte. Ltd.

Anebulo Pharmaceuticals Inc

0.3000
0.0000
Volume:117
Turnover:30.00
Market Cap:12.24M
PE:-1.54
High:0.3000
Open:0.3000
Low:0.3000
Close:0.3000
52wk High:2.90
52wk Low:0.0004
Shares:40.78M
Float Shares:3.40M
Volume Ratio:0.42
T/O Rate:0.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1945
EPS(LYR):-0.2509
ROE:-69.69%
ROA:-45.04%
PB:1.54
PE(LYR):-1.20

Loading ...

Company Profile

Company Name:
Anebulo Pharmaceuticals Inc
Exchange:
EXPERT
Establishment Date:
2020
Employees:
- -
Office Location:
1017 Ranch Road 620 South,Suite 107,Lakeway,Texas,United States
Zip Code:
78734
Fax:
- -
Introduction:
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction. The company's lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist, which is in a Phase II clinical trial to address the unmet medical need for a specific antidote for ACI. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is based in Lakeway, Texas.